Organization: Health Canada
Year: 2024
Month: September
Request Number: A-2024-000126
Request Summary: In respect of the second, newest Abbreviated New Drug Submission (ANDS) for semaglutide (the Second Semaglutide ANDS), provide a copy of the ANDS cover letter of the company (sponsor) who submitted the Second Semaglutide ANDS.
Disposition: Disclosed in part
Number of pages: 3